Thyretain News
-
14th International Thyroid Congress
We will sponsor this year's conference in Paris, France.
-
Diagnostic HYBRIDS Releases Thyretain™ for Specific Detection of Thyroid Stimulating Immunoglobulins
Diagnostic HYBRIDS announces the FDA clearance, for marketing under the 510(k) pre-notification process, of the ThyretainTM TSI Reporter BioAssay.
-
Diagnostic Hybrids Sponsored Graves’ Disease Foundation’s Patient and Family Education Conference
On October 16, 2009, Diagnostic Hybrids was a presenting corporate sponsor at the 2009 Graves’ Patient and Family Education Conference of the Graves’ Disease Foundation.
